New publication showing improved recognition of bacteria helping the development of future antibiotics using Attana’s QCM-technology
Attana’s customer Centro de Investigaciones Biológicas, CSIC has in a collaboration developed methods to identify differences between bacteria and their mutations. This specific detection allows the development of next generation antibiotics that can target one type of bacteria but does not affect others. Next generation antibiotics aim to make patient treatment more effective while lowering the risk of resistant bacteria. Attana’s QCM technology has been applied to determine the kinetic interaction of the molecules that interact specifically with a given bacteria, demonstrating the value